Portfolio company
Nutcracker Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops an automated microfluidic platform for manufacturing mRNA-based therapeutics and vaccines for pharmaceutical partners and medical researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Inside Therapeutics
The company develops microfluidic instruments for encapsulating therapeutic RNA into lipid nanoparticles for pharmaceutical researchers and nanomedicine manufacturers.
Sensible Biotechnologies
This company develops a cell-based platform to produce mRNA for pharmaceutical firms and biotechnology researchers developing therapeutics and vaccines.
Nanofacile
Nanofacile produces a microfluidic platform and kits for lipid nanoparticle formulation to assist researchers and pharmaceutical companies with ribonucleic acid therapy development.
Nuntius Therapeutics
This company develops mRNA and gene-editing therapies using a programmable nanocarrier delivery platform for pharmaceutical companies and research institutions.
Etherna
This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.
NTx Bio
The company produces automated cell-free systems for manufacturing RNA and protein therapeutics for biotechnology and pharmaceutical customers.
ExcepGen
ExcepGen develops a platform for nucleic acid therapeutics to improve the efficacy and tolerability of mRNA-based medicines for biopharmaceutical companies.
Versameb
This biopharmaceutical company develops mRNA-based therapeutics and technology platforms for protein expression to treat patients with unmet medical needs in various disease areas.
